FDA NDC Directory · JSON-LD · Markdown

QELBREE

NDC 17772-133 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Generic nameviloxazine hydrochloride
Labeler / ManufacturerSupernus Pharmaceuticals, Inc
Marketing categoryNew Drug Application (innovator) · App NDA211964
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsVILOXAZINE HYDROCHLORIDE (200 mg/1)
Marketing started20210402
Package count5

External sources

Source: openFDA. Public-domain (CC0).